View Filing Data

CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
CONSOLIDATED BALANCE SHEETS - USD ($) $ in Thousands	Jun. 25, 2011	Dec. 25, 2010
Current assets:
Cash and cash equivalents	$ 161,789	$ 150,348
Accounts receivable, net of reserves of $61,216 and $56,267	963,073	885,784
Inventories, net	926,722	870,206
Deferred income taxes	54,178	48,951
Prepaid expenses and other	243,248	214,013
Total current assets	2,349,010	2,169,302
Property and equipment, net	270,021	252,573
Goodwill	1,512,702	1,424,794
Other intangibles, net	447,501	405,468
Investments and other	304,525	295,334
Total assets	4,883,759	4,547,471
Current liabilities:
Accounts payable	605,785	590,029
Bank credit lines	49,236	41,508
Current maturities of long-term debt	21,186	4,487
Accrued expenses:
Payroll and related	170,314	172,746
Taxes	125,721	91,581
Other	264,703	267,736
Total current liabilities	1,236,945	1,168,087
Long-term debt	372,924	395,309
Deferred income taxes	197,538	190,225
Other liabilities	77,368	76,753
Total liabilities	1,884,775	1,830,374
Redeemable noncontrolling interests	$ 424,164	$ 304,140
Commitments and contingencies
Stockholders' equity:
Preferred stock, $.01 par value, 1,000,000 shares authorized, none outstanding	$ 0	$ 0
Common stock, $.01 par value, 240,000,000 shares authorized, 92,384,610 outstanding on June 25, 2011 and 91,939,477 outstanding on December 25, 2010	924	919
Additional paid-in capital	541,373	601,014
Retained earnings	1,928,138	1,779,178
Accumulated other comprehensive income	102,921	30,514
Total Henry Schein, Inc. stockholders' equity	2,573,356	2,411,625
Noncontrolling interests	1,464	1,332
Total stockholders' equity	2,574,820	2,412,957
Total liabilities, redeemable noncontrolling interests and stockholders' equity	$ 4,883,759	$ 4,547,471

CONSOLIDATED BALANCE SHEETS (Parenthetical) - USD ($) $ in Thousands	Jun. 25, 2011	Dec. 25, 2010
Current assets:
Accounts receivable, reserves	$ 61,216	$ 56,267
Stockholders' equity:
Preferred stock, par value (in dollars per share)	$ 0.01	$ 0.01
Preferred stock, shares authorized (in shares)	1,000,000	1,000,000
Preferred stock, shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.01	$ 0.01
Common stock, shares authorized (in shares)	240,000,000	240,000,000
Common stock, shares outstanding (in shares)	92,384,610	91,939,477

CONSOLIDATED STATEMENTS OF INCOME - USD ($) shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 25, 2011	Jun. 26, 2010
Income Statement [Abstract]
Net sales	$ 2,130,640	$ 1,849,401	$ 4,078,401	$ 3,609,711
Cost of sales	1,518,416	1,303,757	2,900,355	2,551,034
Gross profit	612,224	545,644	1,178,046	1,058,677
Operating expenses:
Selling, general and administrative	461,009	407,638	902,531	804,627
Restructuring costs	0	0	0	12,285
Operating income	151,215	138,006	275,515	241,765
Other income (expense):
Interest income	4,192	3,508	8,125	6,896
Interest expense	(7,902)	(9,185)	(15,987)	(18,272)
Other, net	758	474	1,081	359
Income before taxes, equity in earnings of affiliates and noncontrolling interests	148,263	132,803	268,734	230,748
Income taxes	(47,340)	(41,435)	(86,493)	(73,659)
Equity in earnings of affiliates	4,133	1,795	5,786	3,326
Net income	105,056	93,163	188,027	160,415
Less: Net income attributable to noncontrolling interests	(10,581)	(9,162)	(17,057)	(15,514)
Net income attributable to Henry Schein, Inc.	$ 94,475	$ 84,001	$ 170,970	$ 144,901
Earnings per share attributable to Henry Schein, Inc.:
Basic (in dollars per share)	$ 1.04	$ 0.93	$ 1.88	$ 1.61
Diluted (in dollars per share)	$ 1.01	$ 0.90	$ 1.83	$ 1.56
Weighted-Average Common Shares Outstanding, Basic and Diluted [Abstract]
Basic (in shares)	90,766	90,021	90,710	89,733
Diluted (in shares)	93,446	93,352	93,330	92,984

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY $ in Thousands	6 Months Ended
	Jun. 25, 2011 USD ($) shares
Statement [Line Items]
Beginning Balance	$ 2,412,957
Net income (excluding $16,819 attributable to Redeemable noncontrolling interests)	171,208
Foreign currency translation gain (excluding $2,192 attributable to Redeemable noncontrolling interests)	70,755
Unrealized gain from foreign currency hedging activities, net of tax of $298	1,810
Unrealized investment gain, net of tax benefit of $9	197
Pension adjustment loss, net of tax benefit of $29	(355)
Total comprehensive income	243,615
Dividends paid	(152)
Other adjustments	46
Change in fair value of redeemable securities	(96,740)
Initial noncontrolling interests and adjustments related to business acquisitions	(2,000)
Repurchase and retirement of common stock - Value	(32,098)
Stock issued upon exercise of stock options, including tax benefit of $6,510	34,447
Stock-based compensation expense	17,960
Shares withheld for payroll taxes	(2,912)
Liability for cash settlement stock option awards	(303)
Ending Balance	2,574,820
Common Stock [Member]
Statement [Line Items]
Beginning Balance	$ 919
Beginning Balance, shares (in shares) \| shares	91,939,477
Net income (excluding $16,819 attributable to Redeemable noncontrolling interests)	$ 0
Foreign currency translation gain (excluding $2,192 attributable to Redeemable noncontrolling interests)	0
Unrealized gain from foreign currency hedging activities, net of tax of $298	0
Unrealized investment gain, net of tax benefit of $9	0
Pension adjustment loss, net of tax benefit of $29	0
Dividends paid	0
Other adjustments	0
Change in fair value of redeemable securities	0
Initial noncontrolling interests and adjustments related to business acquisitions	0
Repurchase and retirement of common stock - Value	$ (4)
Repurchase and retirement of common stock - Shares \| shares	(481,093)
Stock issued upon exercise of stock options, including tax benefit of $6,510	$ 7
Stock issued upon exercise of stock options, including tax benefit of $6,510 - shares (in shares) \| shares	742,649
Stock-based compensation expense	$ 3
Stock-based compensation expense - shares (in shares) \| shares	294,383
Shares withheld for payroll taxes	$ (1)
Shares withheld for payroll taxes - shares \| shares	(110,806)
Liability for cash settlement stock option awards	$ 0
Ending Balance	$ 924
Ending Balance, shares (in shares) \| shares	92,384,610
Additional Paid-in Capital [Member]
Statement [Line Items]
Beginning Balance	$ 601,014
Net income (excluding $16,819 attributable to Redeemable noncontrolling interests)	0
Foreign currency translation gain (excluding $2,192 attributable to Redeemable noncontrolling interests)	0
Unrealized gain from foreign currency hedging activities, net of tax of $298	0
Unrealized investment gain, net of tax benefit of $9	0
Pension adjustment loss, net of tax benefit of $29	0
Dividends paid	0
Other adjustments	0
Change in fair value of redeemable securities	(96,740)
Initial noncontrolling interests and adjustments related to business acquisitions	(2,000)
Repurchase and retirement of common stock - Value	(10,084)
Stock issued upon exercise of stock options, including tax benefit of $6,510	34,440
Stock-based compensation expense	17,957
Shares withheld for payroll taxes	(2,911)
Liability for cash settlement stock option awards	(303)
Ending Balance	541,373
Retained Earnings [Member]
Statement [Line Items]
Beginning Balance	1,779,178
Net income (excluding $16,819 attributable to Redeemable noncontrolling interests)	170,970
Foreign currency translation gain (excluding $2,192 attributable to Redeemable noncontrolling interests)	0
Unrealized gain from foreign currency hedging activities, net of tax of $298	0
Unrealized investment gain, net of tax benefit of $9	0
Pension adjustment loss, net of tax benefit of $29	0
Dividends paid	0
Other adjustments	0
Change in fair value of redeemable securities	0
Initial noncontrolling interests and adjustments related to business acquisitions	0
Repurchase and retirement of common stock - Value	(22,010)
Stock issued upon exercise of stock options, including tax benefit of $6,510	0
Stock-based compensation expense	0
Shares withheld for payroll taxes	0
Liability for cash settlement stock option awards	0
Ending Balance	1,928,138
Accumulated Other Comprehensive Income [Member]
Statement [Line Items]
Beginning Balance	30,514
Net income (excluding $16,819 attributable to Redeemable noncontrolling interests)	0
Foreign currency translation gain (excluding $2,192 attributable to Redeemable noncontrolling interests)	70,755
Unrealized gain from foreign currency hedging activities, net of tax of $298	1,810
Unrealized investment gain, net of tax benefit of $9	197
Pension adjustment loss, net of tax benefit of $29	(355)
Dividends paid	0
Other adjustments	0
Change in fair value of redeemable securities	0
Initial noncontrolling interests and adjustments related to business acquisitions	0
Repurchase and retirement of common stock - Value	0
Stock issued upon exercise of stock options, including tax benefit of $6,510	0
Stock-based compensation expense	0
Shares withheld for payroll taxes	0
Liability for cash settlement stock option awards	0
Ending Balance	102,921
Noncontrolling Interests [Member]
Statement [Line Items]
Beginning Balance	1,332
Net income (excluding $16,819 attributable to Redeemable noncontrolling interests)	238
Foreign currency translation gain (excluding $2,192 attributable to Redeemable noncontrolling interests)	0
Unrealized gain from foreign currency hedging activities, net of tax of $298	0
Unrealized investment gain, net of tax benefit of $9	0
Pension adjustment loss, net of tax benefit of $29	0
Dividends paid	(152)
Other adjustments	46
Change in fair value of redeemable securities	0
Initial noncontrolling interests and adjustments related to business acquisitions	0
Repurchase and retirement of common stock - Value	0
Stock issued upon exercise of stock options, including tax benefit of $6,510	0
Stock-based compensation expense	0
Shares withheld for payroll taxes	0
Liability for cash settlement stock option awards	0
Ending Balance	$ 1,464

CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (Parenthetical) $ in Thousands	6 Months Ended
	Jun. 25, 2011 USD ($)
Statement of Stockholders' Equity [Abstract]
Net income attributable to Redeemable noncontrolling interests	$ 16,819
Foreign currency translation gain attributable to Redeemable noncontrolling interests	2,192
Unrealized gain from foreign currency hedging activities, tax	298
Unrealized investment gain, tax benefit	9
Pension adjustment loss, tax benefit	29
Stock issued upon exercise of stock options, tax benefit	$ 6,510

CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	6 Months Ended
	Jun. 25, 2011	Jun. 26, 2010
Cash flows from operating activities:
Net income	$ 188,027	$ 160,415
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization	57,469	50,344
Amortization of bond discount	0	3,135
Stock-based compensation expense	17,960	12,999
Provision for losses on trade and other accounts receivable	2,722	2,322
Benefit from deferred income taxes	(10,265)	(5,831)
Undistributed earnings of affiliates	(5,786)	(3,326)
Other	2,242	2,649
Changes in operating assets and liabilities, net of acquisitions:
Accounts receivable	(9,902)	(33,854)
Inventories	3,902	32,264
Other current assets	(11,100)	(18,411)
Accounts payable and accrued expenses	(49,977)	(73,718)
Net cash provided by operating activities	185,292	128,988
Cash flows from investing activities:
Purchases of fixed assets	(20,764)	(17,542)
Payments for equity investments and business acquisitions, net of cash acquired	(143,636)	(204,598)
Purchases of available-for-sale securities	0	(26,984)
Proceeds from sales of available-for-sale securities	2,150	1,400
Proceeds from maturities of available-for-sale securities	0	11,996
Other	230	307
Net cash used in investing activities	(162,020)	(235,421)
Cash flows from financing activities:
Proceeds from (repayments of) bank borrowings	7,671	(668)
Proceeds from issuance of long-term debt	3,101	0
Principal payments for long-term debt	(23,916)	(50,175)
Proceeds from issuance of stock upon exercise of stock options	27,938	21,036
Payments for repurchases of common stock	(32,098)	0
Excess tax benefits related to stock-based compensation	6,852	6,351
Distributions to noncontrolling shareholders	(6,417)	(7,736)
Acquisitions of noncontrolling interests in subsidiaries	(3,366)	(10,000)
Other	(90)	(180)
Net cash used in financing activities	(20,325)	(41,372)
Net change in cash and cash equivalents	2,947	(147,805)
Effect of exchange rate changes on cash and cash equivalents	8,494	(2,233)
Cash and cash equivalents, beginning of period	150,348	471,154
Cash and cash equivalents, end of period	$ 161,789	$ 321,116

Basis of Presentation	6 Months Ended
Basis of Presentation	Jun. 25, 2011
Notes to Financial Statements [Abstract]
Basis of Presentation	Note 1. Basis of Presentation Our consolidated financial statements include our accounts, as well as those of our wholly-owned and majority-owned subsidiaries. Certain prior period amounts have been reclassified to conform to the current period presentation. Our accompanying unaudited consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States ("U.S. GAAP") for interim financial information and with the instructions to Form 10-Q and Article 10 of Regulation S-X. Accordingly, they do not include all of the information and footnote disclosures required by U.S. GAAP for complete financial statements. The consolidated financial statements reflect all adjustments considered necessary for a fair presentation of the consolidated results of operations and financial position for the interim periods presented. All such adjustments are of a normal recurring nature. These unaudited interim consolidated financial statements should be read in conjunction with the audited consolidated financial statements and notes to the consolidated financial statements contained in our Annual Report on Form 10-K for the year ended December 25, 2010. The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect the reported amounts of assets and liabilities, and disclosure of contingent assets and liabilities, at the date of the financial statements and the reported amounts of revenues and expenses during the reporting period. Actual results could differ from those estimates. The results of operations for the six months ended June 25, 2011 are not necessarily indicative of the results to be expected for any other interim period or for the year ending December 31, 2011.

Segment and Geographic Data

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Segment Data

Note 2. Segment Data

We conduct our business through two reportable segments: healthcare distribution and technology. These segments offer different products and services to the same customer base. The healthcare distribution reportable segment aggregates our dental, medical, animal health and international operating segments. This segment consists of consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

Our dental group serves office-based dental practitioners, schools and other institutions in the combined United States and Canadian dental market. Our medical group serves office-based medical practitioners, surgical centers, other alternate-care settings and other institutions throughout the United States. Our animal health group serves animal health practices and clinics throughout the United States. Our international group serves dental, medical and animal health practitioners in 23 countries outside of North America.

Our technology group provides software, technology and other value-added services to healthcare practitioners, primarily in the United States, Canada, the United Kingdom, Australia and New Zealand. Our value-added practice solutions include practice management software systems for dental and medical practitioners and animal health clinics. Our technology group offerings also include financial services on a non-recourse basis, e-services and continuing education services for practitioners.

The following tables present information about our reportable segments:

	Three Months Ended				Six Months Ended
	June 25,		June 26,		June 25,		June 26,
	2011		2010		2011		2010
Net Sales:
Healthcare distribution (1):
Dental (2)	$	709,338	$	677,560	$	1,372,121	$	1,292,209
Medical (3)		317,263		286,291		637,058		570,880
Animal health (4)		260,307		234,734		490,872		441,380
International (5)		781,675		602,435		1,460,647		1,211,888
Total healthcare distribution		2,068,583		1,801,020		3,960,698		3,516,357
Technology (6)		62,057		48,381		117,703		93,354
Total	$	2,130,640	$	1,849,401	$	4,078,401	$	3,609,711

(1)	Consists of consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

(2)	Consists of products sold in the United States and Canadian dental markets.

(3)	Consists of products sold in the United States' medical market.

(4)	Consists of products sold in the United States' animal health market.

(5)	Consists of products sold in dental, medical and animal health markets, primarily in Europe, Australia and New Zealand.

(6)	Consists of practice management software and other value-added products and services, which are distributed primarily to healthcare providers in the United States, Canada, the United Kingdom, Australia and New Zealand.

	Three Months Ended				Six Months Ended
	June 25,		June 26,		June 25,		June 26,
	2011		2010		2011		2010
Operating Income:
Healthcare distribution	$	134,010	$	121,134	$	243,542	$	209,972
Technology		17,205		16,872		31,973		31,793
Total	$	151,215	$	138,006	$	275,515	$	241,765

Debt

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Debt

Note 3. Debt

On September 5, 2008, we entered into a $400 million revolving credit facility with a $100 million expansion feature. The $400 million credit line expires in September 2013. The interest rate, which was 0.70% during the six months ended June 25, 2011, is based on USD LIBOR plus a spread based on our leverage ratio at the end of each financial reporting quarter. The agreement provides, among other things, that we maintain certain interest coverage and maximum leverage ratios, and contains restrictions relating to subsidiary indebtedness, liens, employee and shareholder loans, disposal of businesses and certain changes in ownership. In addition to the amounts outstanding under our shelf facilities, discussed below, we have outstanding borrowings of approximately $25.0 million under our $400 million credit facility. As of June 25, 2011, there were $9.7 million of letters of credit provided to third parties.

As of June 25, 2011, we had various other short-term bank credit lines available, of which approximately $24.2 million was outstanding. As of June 25, 2011, borrowings under all of our credit lines had a weighted average interest rate of 2.12%.

On August 10, 2010, we entered into $400 million private placement shelf facilities with two insurance companies. These shelf facilities are available through August 2013 on an uncommitted basis. The facilities allow us to issue senior promissory notes to the lenders at a fixed rate based on an agreed upon spread over applicable treasury notes at the time of issuance. The term of each possible issuance will be selected by us and can range from five to 15 years (with an average life no longer than 12 years). The proceeds of any issuances under the facilities will be used for general corporate purposes, including working capital and capital expenditures, to refinance existing indebtedness and/or to fund potential acquisitions. The agreement provides, among other things, that we maintain certain maximum leverage ratios, and contains restrictions relating to subsidiary indebtedness, liens, employee and shareholder loans, disposal of businesses and certain changes in ownership. As of June 25, 2011, we have an outstanding balance under the facilities of $100.0 million at a fixed rate of 3.79%, which is due on September 2, 2020.

Effective December 31, 2009, Butler Animal Health Supply, LLC, or BAHS, a majority-owned subsidiary whose financial information is consolidated with ours, had incurred approximately $320.0 million of debt (of which $37.5 million was provided by Henry Schein, Inc.) in connection with our acquisition of a majority interest in BAHS.

On May 27, 2011, BAHS refinanced the terms and amount of its debt. The refinanced debt consists of the following three components:

Term loan A - $100.0 million repayable in 14 quarterly installments in payment amounts ranging from $1.25 million per quarter for the period September 30, 2011 through June 30, 2012, approximately $1.88 million per quarter for the period September 30, 2012 through June 30, 2013, $2.5 million per quarter for the period September 30, 2013 through June 30, 2014, approximately $3.13 million for the quarter ended September 30, 2014 and a final installment of approximately $74.4 million due on December 31, 2014. Interest on the $100.0 million term loan is charged at LIBOR plus a margin of 3%;

Term loan B - $216.0 million ($55.0 million provided by Henry Schein, Inc.) repayable in 17 quarterly installments of $540 thousand from September 30, 2011 through September 30, 2015, and a final installment of approximately $206.8 million due on December 31, 2015. Interest on the $216.0 million term loan is charged at LIBOR plus a margin of 3.25% with a LIBOR floor of 1.25%; and

Revolver of $50.0 million with interest charged at LIBOR plus a margin of 3%.

The outstanding balance of $280.8 million is reflected in our consolidated balance sheet as of June 25, 2011. Borrowings incurred as part of the acquisition of BAHS are collateralized by assets of BAHS with an aggregate net carrying value of $244.3 million.

Certain of our other subsidiaries maintain credit lines which are collateralized by assets of those subsidiaries with an aggregate net carrying value of $84.8 million.

Prior to the debt refinancing discussed above, the debt incurred as part of the acquisition of BAHS was repayable in 23 quarterly installments of $0.8 million through September 30, 2015, and a final installment of $301.6 million was due on December 31, 2015. Interest on the BAHS debt was charged at LIBOR plus a margin of 3.5% with a LIBOR floor of 2%.

The revised debt agreement continues to provide, among other things, that BAHS maintain certain interest coverage and maximum leverage ratios, and contains restrictions relating to subsidiary indebtedness, capital expenditures, liens, employee and shareholder loans, disposal of businesses and certain changes in ownership. In addition, the revised debt agreement continues to contain provisions which, under certain circumstances, require BAHS to make prepayments based on excess cash flows of BAHS as defined in the debt agreement. The revised debt agreement also contains provisions that require BAHS to hedge risks related to potential rising interest rates. As a result, BAHS entered into a series of interest rate caps, for which we have elected hedge accounting treatment, with a notional amount of $160.0 million, protecting against LIBOR interest rates rising above 3.0% through March 30, 2012.

Redeemable Noncontrolling Interests

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Redeemable Noncontrolling Interests

Note 4. Redeemable Noncontrolling Interests

Some minority shareholders in certain of our subsidiaries have the right, at certain times, to require us to acquire their ownership interest in those entities at fair value. Accounting Standards Codification ("ASC") Topic 480-10 is applicable for noncontrolling interests where we are or may be required to purchase all or a portion of the outstanding interest in a consolidated subsidiary from the noncontrolling interest holder under the terms of a put option contained in contractual agreements. The components of the change in the Redeemable noncontrolling interests for the six months ended June 25, 2011 and the year ended December 25, 2010 are presented in the following table:

	June 25, 2011			December 25, 2010
Balance, beginning of period	$	304,140		$	178,570
Net increase in redeemable noncontrolling interests
due to business acquisitions, net of redemptions		10,354			62,314
Net income attributable to redeemable noncontrolling interests		16,819			26,054
Dividends declared		(6,081	)		(12,360	)
Effect of foreign currency translation attributable to
redeemable noncontrolling interests		2,192			(2,281	)
Change in fair value of redeemable securities		96,740			51,843
Balance, end of period	$	424,164		$	304,140

Changes in the estimated redemption amounts of the noncontrolling interests subject to put options are adjusted at each reporting period with a corresponding adjustment to Additional paid-in capital. Future reductions in the carrying amounts are subject to a "floor" amount that is equal to the fair value of the redeemable noncontrolling interests at the time they were originally recorded. The recorded value of the redeemable noncontrolling interests cannot go below the floor level. These adjustments do not impact the calculation of earnings per share.

Some prior owners of such acquired subsidiaries are eligible to receive additional purchase price cash consideration if certain financial targets are met. For acquisitions completed prior to 2009, we accrue liabilities that may arise from these transactions when we believe that the outcome of the contingency is determinable beyond a reasonable doubt. Starting in our 2009 fiscal year, as required by ASC Topic 805, "Business Combinations," we have accrued liabilities for the estimated fair value of additional purchase price adjustments at the time of the acquisition. Any adjustments to these accrual amounts will be recorded in our consolidated statement of income. For the six months ended June 25, 2011, there were no material adjustments recorded in our consolidated statement of income relating to changes in estimated contingent purchase price liabilities.

Comprehensive Income

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Comprehensive Income

Note 5. Comprehensive Income

Comprehensive income includes certain gains and losses that, under U.S. GAAP, are excluded from net income as such amounts are recorded directly as an adjustment to stockholders' equity. Our comprehensive income is primarily comprised of net income, foreign currency translation adjustments, unrealized gains (losses) on hedging and investment activity and pension adjustments.

The following table summarizes our Accumulated other comprehensive income, net of applicable taxes as of:

	June 25,			December 25,
	2011			2010
Attributable to Redeemable noncontrolling interests:
Foreign currency translation adjustment	$	1,328		$	(864	)

Attributable to Henry Schein, Inc.:
Foreign currency translation adjustment	$	111,893		$	41,138
Unrealized gain (loss) from foreign currency hedging activities		750			(1,060	)
Unrealized investment loss		(979	)		(1,176	)
Pension adjustment loss		(8,743	)		(8,388	)
Accumulated other comprehensive income	$	102,921		$	30,514

Total Accumulated other comprehensive income	$	104,249		$	29,650

The following table summarizes other comprehensive income attributable to our Redeemable noncontrolling interests, net of applicable taxes as follows:

	Three Months Ended					Six Months Ended
	June 25,		June 26,			June 25,		June 26,
	2011		2010			2011		2010

Foreign currency translation adjustment	$	300	$	(4,209	)	$	2,192	$	(7,696	)

The following table summarizes our total comprehensive income, net of applicable taxes as follows:

	Three Months Ended				Six Months Ended
	June 25,		June 26,		June 25,		June 26,
	2011		2010		2011		2010
Comprehensive income attributable to
Henry Schein, Inc.	$	107,560	$	50,845	$	243,377	$	76,858
Comprehensive income attributable to
noncontrolling interests		143		20		238		33
Comprehensive income attributable to
Redeemable noncontrolling interests		10,738		4,933		19,011		7,785
Comprehensive income	$	118,441	$	55,798	$	262,626	$	84,676

Fair Value Measurements

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Fair Value Measurements

Note 6. Fair Value Measurements

ASC Topic 820 "Fair Value Measurements and Disclosures" ("ASC Topic 820") establishes a framework for measuring fair value in generally accepted accounting principles and expands disclosures about fair value measurements. ASC Topic 820 applies under other previously issued accounting pronouncements that require or permit fair value measurements but does not require any new fair value measurements.

ASC Topic 820 defines fair value as the price that would be received to sell an asset or paid to transfer a liability in an orderly transaction between market participants at the measurement date. ASC Topic 820 establishes a fair value hierarchy that distinguishes between (1) market participant assumptions developed based on market data obtained from independent sources (observable inputs) and (2) an entity's own assumptions about market participant assumptions developed based on the best information available in the circumstances (unobservable inputs).

The fair value hierarchy consists of three broad levels, which gives the highest priority to unadjusted quoted prices in active markets for identical assets or liabilities (Level 1) and the lowest priority to unobservable inputs (Level 3). The three levels of the fair value hierarchy under ASC Topic 820 are described as follows:

Level 1- Unadjusted quoted prices in active markets for identical assets or liabilities that are accessible at the measurement date.

Level 2- Inputs other than quoted prices included within Level 1 that are observable for the asset or liability, either directly or indirectly. Level 2 inputs include quoted prices for similar assets or liabilities in active markets; quoted prices for identical or similar assets or liabilities in markets that are not active; inputs other than quoted prices that are observable for the asset or liability; and inputs that are derived principally from or corroborated by observable market data by correlation or other means.

Level 3- Inputs that are unobservable for the asset or liability.

The following section describes the valuation methodologies that we used to measure different financial instruments at fair value.

Cash equivalents and trade receivables

Due to the short-term maturity of such investments, the carrying amounts are a reasonable estimate of fair value.

Long-term investments and notes receivable

There are no quoted market prices available for investments in unconsolidated affiliates and long-term notes receivable; however, we believe the carrying amounts are a reasonable estimate of fair value.

Auction-rate securities

As of June 25, 2011, we have approximately $12.9 million ($11.4 million net of temporary impairments) invested in auction-rate securities ("ARS"), consisting of investments backed by student loans that are backed by the federal government and investments in closed-end municipal bond funds, which are included as part of Investments and other within our consolidated balance sheets. ARS are publicly issued securities that represent long-term investments, typically 10-30 years, in which interest rates had reset periodically (typically every 7, 28 or 35 days) through a "dutch auction" process. Our ARS portfolio is comprised of investments that are rated AAA by major independent rating agencies. Since the middle of February 2008, ARS auctions have failed to settle due to an excess number of sellers compared to buyers. The failure of these auctions has resulted in our inability to liquidate our ARS in the near term. We are currently not aware of any defaults or financial conditions that would negatively affect the issuers' ability to continue to pay interest and principal on our ARS. We continue to earn and receive interest at contractually agreed upon rates.

During the six months ended June 25, 2011, we received approximately $2.2 million of redemptions of our ARS. As of June 25, 2011, we have continued to classify our ARS as Level 3 within the fair value hierarchy due to the lack of observable inputs and the absence of significant refinancing activity.

Based upon the information currently available and the use of a discounted cash flow model, including assumptions for estimated interest rates, timing and amount of cash flows and expected holding period for the ARS portfolio, in accordance with applicable authoritative guidance, our previously recorded cumulative temporary impairment at December 25, 2010 of $1.7 million related to our ARS decreased by $0.2 million during the six months ended June 25, 2011. The temporary impairment has been recorded as part of Accumulated other comprehensive income within the equity section of our consolidated balance sheet.

Accounts payable and accrued expenses

Financial liabilities with carrying values approximating fair value include accounts payable and other accrued liabilities. The carrying value of these financial instruments approximates fair value due to their short maturities.

Debt

The fair value of our debt is estimated based on quoted market prices for our traded debt and on market prices of similar issues for our private debt. The fair value of our debt as of June 25, 2011 and December 25, 2010 was estimated at $443.3 million and $441.3 million, respectively.

Derivative contracts

Derivative contracts are valued using quoted market prices and significant other observable and unobservable inputs. We use derivative instruments to minimize our exposure to fluctuations in interest rates and foreign currency exchange rates. Our derivative instruments primarily include interest rate caps related to our long-term floating rate debt and foreign currency forward agreements related to intercompany loans and certain forecasted inventory purchase commitments with suppliers.

The fair values for the majority of our foreign currency and interest rate derivative contracts are obtained by comparing our contract rate to a published forward price of the underlying market rates, which is based on market rates for comparable transactions and are classified within Level 2 of the fair value hierarchy.

Redeemable noncontrolling interests

Some minority shareholders in certain of our subsidiaries have the right, at certain times, to require us to acquire their ownership interest in those entities at fair value based on third-party valuations. The noncontrolling interests subject to put options are adjusted to their estimated redemption amounts each reporting period with a corresponding adjustment to Additional paid-in capital. Future reductions in the carrying amounts are subject to a "floor" amount that is equal to the fair value of the redeemable noncontrolling interests at the time they were originally recorded. The recorded value of the redeemable noncontrolling interests cannot go below the floor level. These adjustments will not impact the calculation of earnings per share. The details of the changes in Redeemable noncontrolling interests are presented in Note 4.

The following table presents our assets and liabilities that are measured and recognized at fair value on a recurring basis classified under the appropriate level of the fair value hierarchy as of June 25, 2011 and December 25, 2010:

	June 25, 2011
	Level 1		Level 2		Level 3		Total

Assets:
Available-for-sale securities	$	-	$	-	$	11,405	$	11,405
Derivative contracts		-		1,463		-		1,463
Total assets	$	-	$	1,463	$	11,405	$	12,868


Liabilities:
Derivative contracts	$	-	$	1,057	$	-	$	1,057
Total liabilities	$	-	$	1,057	$	-	$	1,057

Redeemable noncontrolling interests	$	-	$	-	$	424,164	$	424,164

	December 25, 2010
	Level 1		Level 2		Level 3		Total

Assets:
Available-for-sale securities	$	-	$	-	$	13,367	$	13,367
Derivative contracts		-		1,213		-		1,213
Total assets	$	-	$	1,213	$	13,367	$	14,580


Liabilities:
Derivative contracts	$	-	$	2,771	$	-	$	2,771
Total liabilities	$	-	$	2,771	$	-	$	2,771

Redeemable noncontrolling interests	$	-	$	-	$	304,140	$	304,140

The following table presents a reconciliation of our assets and liabilities measured at fair value on a recurring basis using unobservable inputs (Level 3):

	Level 3 (1)
Balance, December 25, 2010	$	317,507
Change in redeemable noncontrolling interests		120,024
Redemptions at par		(2,150	)
Gain reported in accumulated other comprehensive income		188
Balance, June 25, 2011	$	435,569

	Level 3 (1)
Balance, December 26, 2009	$	199,164
Change in redeemable noncontrolling interests		162,529
Redemptions at par		(3,080	)
Gain reported in accumulated other comprehensive income		102
Balance, June 26, 2010	$	358,715

(1)	Level 3 amounts consist of closed-end municipal bond funds, student loan backed auction-rate securities and redeemable noncontrolling interests. See Note 4 for the components of the changes in Redeemable noncontrolling interests.

Business Acquisitions

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Business Acquisitions

Note 7. Business Acquisitions

The operating results of all acquisitions are reflected in our financial statements from their respective acquisition dates.

On December 31, 2010, we acquired 100% of the outstanding shares of Provet Holdings Limited (ASX: PVT), Australia's largest distributor of veterinary products with sales in its 2010 fiscal year of approximately $278 million, for approximately $91 million, in a cash-for-stock exchange.

We completed other acquisitions during the six months ended June 25, 2011, the operating results of which are reflected in our financial statements from their respective acquisition dates. All acquisitions individually and in the aggregate had an immaterial impact on our reported operating results. Total acquisition costs incurred in the six months ended June 25, 2011 were immaterial to our financial results.

Effective December 31, 2009, we acquired a majority interest in Butler Animal Health Holding Company, LLC ("Butler Holding"), the holding company of BAHS, a distributor of companion animal health supplies to veterinarians. BAHS further complements our domestic and international animal health operations and accordingly has been included in our Animal health operating segment, which is reported as part of Healthcare distribution. We contributed certain assets and liabilities with a net book value of approximately $86.0 million related to our United States animal health business to BAHS and paid approximately $42.0 million in cash to acquire 50.1% of the equity interests in Butler Holding indirectly through W.A. Butler Company, a holding company that is partially owned by Oak Hill Capital Partners ("OHCP"). As part of a recapitalization at closing, BAHS combined with our animal health business to form Butler Schein Animal Health ("BSAH"), while incurring approximately $127.0 million in incremental debt used primarily to finance Butler Holding stock redemptions. As a result, BSAH had incurred $320.0 million of debt at closing, $37.5 million of which was provided by Henry Schein, Inc. and is eliminated in the accompanying consolidated financial statements. See below for a discussion of the refinancing of debt incurred as part of the acquisition of BAHS.

Total consideration for the acquisition of BAHS, including $96.1 million of value for noncontrolling interests, was $351.1 million, summarized as follows:

Net cash consideration paid by Henry Schein, Inc.	$	41,990
Net book value of the United States animal health operations' assets and liabilities contributed		86,048
Fair value of noncontrolling interest in BAHS		96,110
Incremental debt incurred		127,000
Total consideration	$	351,148

We estimated the $96.1 million fair value of noncontrolling interest in BAHS as of the acquisition date by applying an income approach as our valuation technique. Our income approach followed a discounted cash flow method, which applied our best estimates of future cash flows and an estimated terminal value discounted to present value at a rate of return taking into account the relative risk of the cash flows. To confirm the reasonableness of the value derived from the income approach, we also analyzed the values of comparable companies which are publicly traded.

The total consideration of $351.1 million was allocated as follows:

Net assets of BAHS at fair value:
Current assets	$	164,789
Intangible assets:
Trade name (useful life 3 years)		10,000
Customer relationships (useful life 12 years)		140,000
Non-compete agreements (useful life 2 years)		2,600
Goodwill		270,714
Other assets		14,138
Current liabilities		(62,770	)
Bank indebtedness		(200,100	)
Deferred income tax liabilities		(74,271	)
Net book value of our assets and liabilities contributed		86,048
Total allocation of consideration	$	351,148

The goodwill recognized is primarily attributable to expected synergies and the assembled workforce of BAHS. The goodwill is not expected to be tax deductible for income tax purposes. As a result of our contributed business being under the control of Henry Schein, Inc. before and after the transaction, the assets and liabilities of this business remain at their original historical accounting basis in the accompanying consolidated financial statements.

In connection with the acquisition of a majority interest in BAHS, we entered into (i) a Put Rights Agreement with OHCP and Butler Holding (the "Oak Hill Put Rights Agreement"), and (ii) a Put Rights Agreement with Burns Veterinary Supply, Inc. ("Burns") and Butler Holding (the "Burns Put Rights Agreement" and together with the Oak Hill Put Rights Agreement, the "Put Rights Agreements"), which provide each of OHCP and Burns with certain rights to require us to purchase their respective direct and indirect ownership interests in Butler Holding at fair value based on third-party valuations ("Put Rights"). Our maximum annual payment to OHCP under the Oak Hill Put Rights Agreement will not exceed $125.0 million for the first year during which OHCP can exercise its rights, $137.5 million for the second year and $150.0 million for the third year and for each year thereafter. Pursuant to the Burns Put Rights Agreement, Burns can exercise its Put Rights from and after December 31, 2014, at which time Burns will be permitted to sell to us up to 20% of its closing date ownership interest in Butler Holding each year. If OHCP still holds ownership interests in Butler Holding at the time the Burns Put Rights begin, then the put amounts payable by us to OHCP and Burns in any year will not exceed $150.0 million in the aggregate. As a result of the Put Right Agreements, the noncontrolling interest in BAHS has been reflected as part of Redeemable noncontrolling interests in the accompanying consolidated balance sheet.

On May 27, 2011, BAHS refinanced the terms and amount of its debt. The refinanced debt consists of the following three components:

Revolver of $50.0 million with interest charged at LIBOR plus a margin of 3%.

The revised debt agreement continues to contain provisions which, under certain circumstances, require BAHS to make prepayments based on excess cash flows of BAHS as defined in the debt agreement. The revised debt agreement also continues to contain provisions that require BAHS to hedge risks related to potential rising interest rates. As a result, BAHS entered into a series of interest rate caps, for which we have elected hedge accounting treatment, with a notional amount of $160.0 million, protecting against LIBOR interest rates rising above 3.0% through March 30, 2012.

Plan of Restructuring

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Plans of Restructuring

Note 8. Plan of Restructuring

During the first quarter of 2010, we completed a restructuring in order to reduce operating expenses. This restructuring included headcount reductions of 184 positions, as well as the closing of a number of smaller locations.

For the six months ended June 26, 2010, we recorded restructuring costs of approximately $12.3 million (approximately $8.3 million after taxes) consisting of employee severance pay and benefits, facility closing costs, representing primarily lease termination and asset write-off costs, and outside professional and consulting fees directly related to the restructuring plan.

The costs associated with these restructurings are included in a separate line item, "Restructuring costs" within our consolidated statements of income.

The following table shows the amounts expensed and paid for restructuring costs that were incurred during our 2010 fiscal year and the remaining accrued balance of restructuring costs as of June 25, 2011, which is included in Accrued expenses: Other and Other liabilities within our consolidated balance sheet:

	Balance at December 25, 2010		Provision		Payments and Other Adjustments		Balance at June 25, 2011
Severance costs (1)	$	1,992	$	-	$	1,015	$	977
Facility closing costs (2)		2,351		-		829		1,522
Total	$	4,343	$	-	$	1,844	$	2,499

(1)	Represents salaries and related benefits for employees separated from the Company.

(2)	Represents costs associated with the closing of certain smaller facilities (primarily lease termination costs) and property and equipment write-offs.

The following table shows, by reportable segment, the restructuring costs incurred during our 2010 fiscal year and the remaining accrued balance of restructuring costs as of June 25, 2011:

	Balance at December 25, 2010		Provision		Payments and Other Adjustments		Balance at June 25, 2011
Healthcare distribution	$	4,343	$	-	$	1,844	$	2,499
Technology		-		-		-		-
Total	$	4,343	$	-	$	1,844	$	2,499

Earnings Per Share

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Earnings Per Share

Note 9. Earnings Per Share

Basic earnings per share is computed by dividing net income attributable to Henry Schein, Inc. by the weighted-average number of common shares outstanding for the period. Our diluted earnings per share is computed similarly to basic earnings per share, except that it reflects the effect of common shares issuable upon vesting of restricted stock and upon exercise of stock options using the treasury stock method in periods in which they have a dilutive effect.

For the three and six months ended June 26, 2010, diluted earnings per share includes the effect of common shares issuable upon conversion of our convertible debt. During this period, the debt was convertible at a premium as a result of the conditions of the debt. As a result, the amount in excess of the principal is presumed to be settled in common shares and is reflected in our calculation of diluted earnings per share.

A reconciliation of shares used in calculating earnings per basic and diluted share follows:

	Three Months Ended		Six Months Ended
	June 25,	June 26,	June 25,	June 26,
	2011	2010	2011	2010
Basic	90,766	90,021	90,710	89,733
Effect of dilutive securities:
Stock options, restricted stock and restricted units	2,680	2,286	2,620	2,289
Effect of assumed conversion of convertible debt	-	1,045	-	962
Diluted	93,446	93,352	93,330	92,984

Weighted-average options to purchase 990 thousand shares of common stock at exercise prices ranging from $59.89 to $62.05 per share that were outstanding during the three months ended June 26, 2010 were excluded from the computation of diluted earnings per share. Weighted-average options to purchase 6 thousand shares of common stock at an exercise price of $69.45 and 990 thousand shares of common stock at exercise prices ranging from $59.89 to $62.05 per share that were outstanding during the six months ended June 25, 2011 and June 26, 2010, respectively, were excluded from the computation of diluted earnings per share. In each of these periods, such options' exercise prices exceeded the average market price of our common stock, thereby causing the effect of such options to be anti-dilutive.

On September 3, 2010, we redeemed all of our 3% convertible contingent notes originally due in 2034 (the "Convertible Notes") for approximately $240 million in cash and issued 732 thousand shares of our common stock. The effect of assumed conversion of our Convertible Notes, as it relates to the impact on diluted earnings per share, was included through September 3, 2010.

Income Taxes	6 Months Ended
Income Taxes	Jun. 25, 2011
Notes to Financial Statements [Abstract]
Income Taxes	Note 10. Income Taxes For the six months ended June 25, 2011, our effective tax rate from operations was 32.2% compared to 31.9% for the prior year period. The difference between our effective tax rates and the federal statutory tax rates for both periods primarily relates to state and foreign income taxes. The total amount of unrecognized tax benefits as of June 25, 2011 was approximately $29.0 million, all of which would affect the effective tax rate if recognized. It is expected that the amount of unrecognized tax benefits will change in the next 12 months; however, we do not expect the change to have a material impact on our consolidated financial statements. The total amounts of interest and penalties were approximately $6.1 million and $0, respectively, for the six months ended June 25, 2011. The tax years subject to examination by major tax jurisdictions include the years 2006 and forward by the U.S. Internal Revenue Service, the years 1997 and forward for certain states and the years 2003 and forward for certain foreign jurisdictions.

Derivatives and Hedging Activities	6 Months Ended
Derivatives and Hedging Activities	Jun. 25, 2011
Notes to Financial Statements [Abstract]
Derivatives and Hedging Activities	Note 11. Derivatives and Hedging Activities We are exposed to market risks, which include changes in interest rates, as well as changes in foreign currency exchange rates as measured against the U.S. dollar and each other, and changes to the credit markets. We attempt to minimize these risks by primarily using interest rate cap agreements, foreign currency forward contracts and by maintaining counter-party credit limits. These hedging activities provide only limited protection against interest rate, currency exchange and credit risks. Factors that could influence the effectiveness of our hedging programs include interest rate volatility, currency markets and availability of hedging instruments and liquidity of the credit markets. All foreign currency forward and interest rate cap contracts that we enter into are components of hedging programs and are entered into for the sole purpose of hedging an existing or anticipated interest rate and currency exposure. We do not enter into such contracts for speculative purposes and we manage our credit risks by diversifying our investments, maintaining a strong balance sheet and having multiple sources of capital. Fluctuations in the value of certain foreign currencies as compared to the U.S. dollar may positively or negatively affect our revenues, gross margins, operating expenses and retained earnings, all of which are expressed in U.S. dollars. Where we deem it prudent, we engage in hedging programs using primarily foreign currency forward and interest rate caps contracts aimed at limiting the impact of foreign currency exchange rate and interest rate fluctuations on earnings. We purchase short-term (i.e., 12 months or less) foreign currency forward contracts to protect against currency exchange risks associated with intercompany loans due from our international subsidiaries and the payment of merchandise purchases to our foreign suppliers. We purchase interest rate caps to protect against interest rate risk on variable rate debt payable to third parties. We do not hedge the translation of foreign currency profits into U.S. dollars, as we regard this as an accounting exposure, not an economic exposure. The impact of our hedging activities has historically not had a material impact on our consolidated financial statements. Accordingly, additional disclosures related to derivatives and hedging activities required by ASC Topic 815 have been omitted.

Stock-Based Compensation

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Employee Benefit Plans

Note 12. Stock-Based Compensation

Our accompanying unaudited consolidated statements of income reflect share-based pretax compensation expense of $9.6 million ($6.5 million after-tax) and $18.0 million ($12.2 million after-tax) for the three and six months ended June 25, 2011, respectively, and $6.9 million ($4.8 million after-tax) and $13.0 million ($8.9 million after-tax) for the three and six months ended June 26, 2010, respectively.

Stock-based compensation represents the cost related to stock-based awards granted to employees and non-employee directors. We measure stock-based compensation at the grant date, based on the estimated fair value of the award, and recognize the cost (net of estimated forfeitures) as compensation expense on a straight-line basis over the requisite service period. Our stock-based compensation expense is reflected in selling, general and administrative expenses in our consolidated statements of income.

Stock-based awards are provided to certain employees and non-employee directors under the terms of our 1994 Stock Incentive Plan, as amended, and our 1996 Non-Employee Director Stock Incentive Plan, as amended (together, the "Plans"). The Plans are administered by the Compensation Committee of the Board of Directors. Prior to March 2009, awards under the Plans principally included a combination of at-the-money stock options and restricted stock (including restricted stock units). In March 2009, March 2010 and March 2011, equity-based awards were granted solely in the form of restricted stock and restricted stock units, with the exception of stock options for certain pre-existing contractual obligations.

Grants of restricted stock are common stock awards granted to recipients with specified vesting provisions. We issue restricted stock that vests solely based on the recipient's continued service over time (four-year cliff vesting) and restricted stock that vests based on our achieving specified performance measurements and the recipient's continued service over time (three-year cliff vesting).

With respect to time-based restricted stock, we estimate the fair value on the date of grant based on our closing stock price. With respect to performance-based restricted stock, the number of shares that ultimately vest and are received by the recipient is based upon our performance as measured against specified targets over a three-year period as determined by the Compensation Committee of the Board of Directors. Although there is no guarantee that performance targets will be achieved, we estimate the fair value of performance-based restricted stock, based on our closing stock price at time of grant.

The Plans provide for adjustments to the performance-based restricted stock targets for significant events such as acquisitions, divestitures, new business ventures and share repurchases. Over the performance period, the number of shares of common stock that will ultimately vest and be issued and the related compensation expense is adjusted upward or downward based upon our estimation of achieving such performance targets. The ultimate number of shares delivered to recipients and the related compensation cost recognized as an expense will be based on our actual performance metrics as defined under the Plans.

Restricted stock units are awards that we grant to certain employees that entitle the recipient to shares of common stock upon vesting. We grant restricted stock units with the same time-based and performance-based vesting that we use for restricted stock. The fair value of restricted stock units is determined on the date of grant, based on our closing stock price.

Total unrecognized compensation cost related to non-vested awards as of June 25, 2011 was $84.2 million, which is expected to be recognized over a weighted-average period of approximately 2.4 years.

The following weighted-average assumptions were used in determining the fair values of stock options using the Black-Scholes valuation model:

	2011	2010
Expected dividend yield	0%	0%
Expected stock price volatility	20%	20%
Risk-free interest rate	2.13%	2.37%
Expected life of options (years)	4.75	4.5

The following table summarizes stock option activity under the Plans during the six months ended June 25, 2011:

	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years	Aggregate Intrinsic Value
Outstanding at beginning of period		5,012		$	43.05
Granted		10			69.45
Exercised		(743	)		37.85
Forfeited		(15	)		39.72
Outstanding at end of period		4,264		$	44.02	4.4	$	108,750

Options exercisable at end of period		3,972		$	42.92	4.2	$	105,655

The following tables summarize the status of our non-vested restricted stock/units for the six months ended June 25, 2011:

	Time-Based Restricted Stock/Units
	Shares/Units			Weighted Average Grant Date Fair Value				Aggregate Intrinsic Value
Outstanding at beginning of period		743		$	34,804
Granted		230			15,981
Vested		(85	)		(4,369	)
Forfeited		(8	)		(381	)
Outstanding at end of period		880		$	46,035		$	61,212

	Performance-Based Restricted Stock/Units
	Shares/Units			Weighted Average Grant Date Fair Value				Aggregate Intrinsic Value
Outstanding at beginning of period		1,347		$	42,083
Granted		451			32,339
Vested		(45	)		(2,720	)
Forfeited		(7	)		(349	)
Outstanding at end of period		1,746		$	71,353		$	121,350

Supplemental Cash Flow Information

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Supplemental Cash Flow Information

Note 13. Supplemental Cash Flow Information

Cash paid for interest and income taxes was:

	Six Months Ended
	June 25, 2011		June 26, 2010
Interest	$	16,159	$	9,824
Income taxes		81,235		62,642

During the six months ended June 25, 2011, we had a $2.1 million non-cash net unrealized gain related to hedging activities. During the six months ended June 26, 2010, we had a $23.0 million non-cash net unrealized loss related to hedging activities.

Segment and Geographic Data (Tables)

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Business Segments [Text Block]

The following tables present information about our reportable segments:

	Three Months Ended				Six Months Ended
	June 25,		June 26,		June 25,		June 26,
	2011		2010		2011		2010
Net Sales:
Healthcare distribution (1):
Dental (2)	$	709,338	$	677,560	$	1,372,121	$	1,292,209
Medical (3)		317,263		286,291		637,058		570,880
Animal health (4)		260,307		234,734		490,872		441,380
International (5)		781,675		602,435		1,460,647		1,211,888
Total healthcare distribution		2,068,583		1,801,020		3,960,698		3,516,357
Technology (6)		62,057		48,381		117,703		93,354
Total	$	2,130,640	$	1,849,401	$	4,078,401	$	3,609,711

(1)	Consists of consumable products, small equipment, laboratory products, large equipment, equipment repair services, branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, infection-control products and vitamins.

(2)	Consists of products sold in the United States and Canadian dental markets.

(3)	Consists of products sold in the United States' medical market.

(4)	Consists of products sold in the United States' animal health market.

(5)	Consists of products sold in dental, medical and animal health markets, primarily in Europe, Australia and New Zealand.

(6)	Consists of practice management software and other value-added products and services, which are distributed primarily to healthcare providers in the United States, Canada, the United Kingdom, Australia and New Zealand.

	Three Months Ended				Six Months Ended
	June 25,		June 26,		June 25,		June 26,
	2011		2010		2011		2010
Operating Income:
Healthcare distribution	$	134,010	$	121,134	$	243,542	$	209,972
Technology		17,205		16,872		31,973		31,793
Total	$	151,215	$	138,006	$	275,515	$	241,765

Redeemable Noncontrolling Interests (Tables)

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Change in Fair Value of Redeemable Noncontrolling Interests

The components of the change in the Redeemable noncontrolling interests for the six months ended June 25, 2011 and the year ended December 25, 2010 are presented in the following table:

	June 25, 2011			December 25, 2010
Balance, beginning of period	$	304,140		$	178,570
Net increase in redeemable noncontrolling interests
due to business acquisitions, net of redemptions		10,354			62,314
Net income attributable to redeemable noncontrolling interests		16,819			26,054
Dividends declared		(6,081	)		(12,360	)
Effect of foreign currency translation attributable to
redeemable noncontrolling interests		2,192			(2,281	)
Change in fair value of redeemable securities		96,740			51,843
Balance, end of period	$	424,164		$	304,140

Comprehensive Income (Tables)

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Accumulated Other Comprehensive Income Net Of Tax Disclosure [Text Block]

The following table summarizes our Accumulated other comprehensive income, net of applicable taxes as of:

	June 25,			December 25,
	2011			2010
Attributable to Redeemable noncontrolling interests:
Foreign currency translation adjustment	$	1,328		$	(864	)

Attributable to Henry Schein, Inc.:
Foreign currency translation adjustment	$	111,893		$	41,138
Unrealized gain (loss) from foreign currency hedging activities		750			(1,060	)
Unrealized investment loss		(979	)		(1,176	)
Pension adjustment loss		(8,743	)		(8,388	)
Accumulated other comprehensive income	$	102,921		$	30,514

Total Accumulated other comprehensive income	$	104,249		$	29,650

Other Comprehensive Income Attributable To Redeemable Noncontrolling Interests Net Of Tax [Text Block]

The following table summarizes other comprehensive income attributable to our Redeemable noncontrolling interests, net of applicable taxes as follows:

	Three Months Ended					Six Months Ended
	June 25,		June 26,			June 25,		June 26,
	2011		2010			2011		2010

Foreign currency translation adjustment	$	300	$	(4,209	)	$	2,192	$	(7,696	)

Total Comprehensive Income Net Of Tax [Text Block]

The following table summarizes our total comprehensive income, net of applicable taxes as follows:

	Three Months Ended				Six Months Ended
	June 25,		June 26,		June 25,		June 26,
	2011		2010		2011		2010
Comprehensive income attributable to
Henry Schein, Inc.	$	107,560	$	50,845	$	243,377	$	76,858
Comprehensive income attributable to
noncontrolling interests		143		20		238		33
Comprehensive income attributable to
Redeemable noncontrolling interests		10,738		4,933		19,011		7,785
Comprehensive income	$	118,441	$	55,798	$	262,626	$	84,676

Fair Value Measurements (Tables)

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Fair value, assets and liabilities measured and recognized on a recurring basis

	June 25, 2011
	Level 1		Level 2		Level 3		Total

Assets:
Available-for-sale securities	$	-	$	-	$	11,405	$	11,405
Derivative contracts		-		1,463		-		1,463
Total assets	$	-	$	1,463	$	11,405	$	12,868


Liabilities:
Derivative contracts	$	-	$	1,057	$	-	$	1,057
Total liabilities	$	-	$	1,057	$	-	$	1,057

Redeemable noncontrolling interests	$	-	$	-	$	424,164	$	424,164

	December 25, 2010
	Level 1		Level 2		Level 3		Total

Assets:
Available-for-sale securities	$	-	$	-	$	13,367	$	13,367
Derivative contracts		-		1,213		-		1,213
Total assets	$	-	$	1,213	$	13,367	$	14,580


Liabilities:
Derivative contracts	$	-	$	2,771	$	-	$	2,771
Total liabilities	$	-	$	2,771	$	-	$	2,771

Redeemable noncontrolling interests	$	-	$	-	$	304,140	$	304,140

Reconciliation of assets and redeemable noncontrolling interests measured at fair value on a recurring basis using unobservable inputs (Level 3)

The following table presents a reconciliation of our assets and liabilities measured at fair value on a recurring basis using unobservable inputs (Level 3):

	Level 3 (1)
Balance, December 25, 2010	$	317,507
Change in redeemable noncontrolling interests		120,024
Redemptions at par		(2,150	)
Gain reported in accumulated other comprehensive income		188
Balance, June 25, 2011	$	435,569

	Level 3 (1)
Balance, December 26, 2009	$	199,164
Change in redeemable noncontrolling interests		162,529
Redemptions at par		(3,080	)
Gain reported in accumulated other comprehensive income		102
Balance, June 26, 2010	$	358,715

(1)	Level 3 amounts consist of closed-end municipal bond funds, student loan backed auction-rate securities and redeemable noncontrolling interests. See Note 4 for the components of the changes in Redeemable noncontrolling interests.

Business Acquisitions (Tables)

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Schedule of purchase price allocation

Total consideration for the acquisition of BAHS, including $96.1 million of value for noncontrolling interests, was $351.1 million, summarized as follows:

Net cash consideration paid by Henry Schein, Inc.	$	41,990
Net book value of the United States animal health operations' assets and liabilities contributed		86,048
Fair value of noncontrolling interest in BAHS		96,110
Incremental debt incurred		127,000
Total consideration	$	351,148

The total consideration of $351.1 million was allocated as follows:

Net assets of BAHS at fair value:
Current assets	$	164,789
Intangible assets:
Trade name (useful life 3 years)		10,000
Customer relationships (useful life 12 years)		140,000
Non-compete agreements (useful life 2 years)		2,600
Goodwill		270,714
Other assets		14,138
Current liabilities		(62,770	)
Bank indebtedness		(200,100	)
Deferred income tax liabilities		(74,271	)
Net book value of our assets and liabilities contributed		86,048
Total allocation of consideration	$	351,148

Plan of Restructuring (Tables)

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Schedule of Restructuring Reserve by Type of Cost

	Balance at December 25, 2010		Provision		Payments and Other Adjustments		Balance at June 25, 2011
Severance costs (1)	$	1,992	$	-	$	1,015	$	977
Facility closing costs (2)		2,351		-		829		1,522
Total	$	4,343	$	-	$	1,844	$	2,499

(1)	Represents salaries and related benefits for employees separated from the Company.

(2)	Represents costs associated with the closing of certain smaller facilities (primarily lease termination costs) and property and equipment write-offs.

Schedule of Restructuring Reserve by Segment

The following table shows, by reportable segment, the restructuring costs incurred during our 2010 fiscal year and the remaining accrued balance of restructuring costs as of June 25, 2011:

	Balance at December 25, 2010		Provision		Payments and Other Adjustments		Balance at June 25, 2011
Healthcare distribution	$	4,343	$	-	$	1,844	$	2,499
Technology		-		-		-		-
Total	$	4,343	$	-	$	1,844	$	2,499

Earnings Per Share (Tables)

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Reconciliation Of Basic And Diluted Shares Used To Calculate Earnings Per Share [Text Block]

A reconciliation of shares used in calculating earnings per basic and diluted share follows:

	Three Months Ended		Six Months Ended
	June 25,	June 26,	June 25,	June 26,
	2011	2010	2011	2010
Basic	90,766	90,021	90,710	89,733
Effect of dilutive securities:
Stock options, restricted stock and restricted units	2,680	2,286	2,620	2,289
Effect of assumed conversion of convertible debt	-	1,045	-	962
Diluted	93,446	93,352	93,330	92,984

Stock-Based Compensation (Tables)

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Weighted-Average Assumptions Used in Determining the Fair Values of Stock Options Using the Black-Scholes Valuation Model

The following weighted-average assumptions were used in determining the fair values of stock options using the Black-Scholes valuation model:

	2011	2010
Expected dividend yield	0%	0%
Expected stock price volatility	20%	20%
Risk-free interest rate	2.13%	2.37%
Expected life of options (years)	4.75	4.5

Summary of the Stock Option Activity Under the Plans

The following table summarizes stock option activity under the Plans during the six months ended June 25, 2011:

	Shares			Weighted Average Exercise Price		Weighted Average Remaining Contractual Life in Years	Aggregate Intrinsic Value
Outstanding at beginning of period		5,012		$	43.05
Granted		10			69.45
Exercised		(743	)		37.85
Forfeited		(15	)		39.72
Outstanding at end of period		4,264		$	44.02	4.4	$	108,750

Options exercisable at end of period		3,972		$	42.92	4.2	$	105,655

Status of Non-Vested Restricted Shares/Units

The following tables summarize the status of our non-vested restricted stock/units for the six months ended June 25, 2011:

	Time-Based Restricted Stock/Units
	Shares/Units			Weighted Average Grant Date Fair Value				Aggregate Intrinsic Value
Outstanding at beginning of period		743		$	34,804
Granted		230			15,981
Vested		(85	)		(4,369	)
Forfeited		(8	)		(381	)
Outstanding at end of period		880		$	46,035		$	61,212

	Performance-Based Restricted Stock/Units
	Shares/Units			Weighted Average Grant Date Fair Value				Aggregate Intrinsic Value
Outstanding at beginning of period		1,347		$	42,083
Granted		451			32,339
Vested		(45	)		(2,720	)
Forfeited		(7	)		(349	)
Outstanding at end of period		1,746		$	71,353		$	121,350

Supplemental Cash Flow Information (Tables)

6 Months Ended

Jun. 25, 2011

Notes to Financial Statements [Abstract]

Cash Paid for Interest and Income Taxes [Text Block]

Cash paid for interest and income taxes was:

	Six Months Ended
	June 25, 2011		June 26, 2010
Interest	$	16,159	$	9,824
Income taxes		81,235		62,642

Segment and Geographic Data (Details) $ in Thousands	3 Months Ended		6 Months Ended
Segment and Geographic Data (Details) $ in Thousands	Jun. 25, 2011 USD ($)	Jun. 26, 2010 USD ($)	Jun. 25, 2011 USD ($)	Jun. 26, 2010 USD ($)
Notes to Financial Statements [Abstract]
Number of reportable segments			2
Number of countries served by our international group outside of North America			23
Segment Reporting Information [Line Items]
Net sales	$ 2,130,640	$ 1,849,401	$ 4,078,401	$ 3,609,711
Operating income	151,215	138,006	275,515	241,765
Healthcare Distribution [Member]
Segment Reporting Information [Line Items]
Net sales	2,068,583	1,801,020	3,960,698	3,516,357
Operating income	134,010	121,134	243,542	209,972
Healthcare Distribution [Member] \| Dental [Member]
Segment Reporting Information [Line Items]
Net sales	709,338	677,560	1,372,121	1,292,209
Healthcare Distribution [Member] \| Medical [Member]
Segment Reporting Information [Line Items]
Net sales	317,263	286,291	637,058	570,880
Healthcare Distribution [Member] \| Animal Health [Member]
Segment Reporting Information [Line Items]
Net sales	260,307	234,734	490,872	441,380
Healthcare Distribution [Member] \| International [Member]
Segment Reporting Information [Line Items]
Net sales	781,675	602,435	1,460,647	1,211,888
Technology [Member]
Segment Reporting Information [Line Items]
Net sales	62,057	48,381	117,703	93,354
Operating income	$ 17,205	$ 16,872	$ 31,973	$ 31,793

Debt (Details) - USD ($) $ in Thousands	6 Months Ended
Debt (Details) - USD ($) $ in Thousands	Jun. 25, 2011	Dec. 25, 2010	Dec. 31, 2009
Line of Credit Facility [Line Items]
Bank credit lines	$ 49,236	$ 41,508
Weighted average interest rate on borrowings under credit lines (in hundredths)	2.12%
Debt Instrument [Line Items]
Collateralized BAHS assets for BAHS debt	$ 244,300
Collateralized subsidiary assets for other subsidiary credit lines	84,800
Notional amount of interest rate caps related to Butler debt	$ 160,000
Interest rate caps on debt protecting against LIBOR interest rate (in hundredths)	3.00%
Private placement facilities [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 400,000
Number of insurance companies providing private placement facilities (in number of insurance companies)	2
Minimum Term Of Issuances Under Private Placement Facilities	five
Maximum Term Of Issuances Under Private Placement Facilities	15
Maximum Average Term Of Issuances Under Private Placement Facilities	12
Debt instrument carrying amount, gross	$ 100,000
Debt Instrument, Interest Rate, Stated Percentage (in hundredths)	3.79%
Debt incurred as part of acquisition of Butler Animal Health Supply, LLC [Member]
Debt Instrument [Line Items]
Debt instrument carrying amount, gross	$ 280,800
Butler Schein Animal Health Debt At Closing			$ 320,000
Intercompany Debt Provided Balance Amount			$ 37,500
Number of quarterly installments to repay debt from BAHS acquisition	23
Amount of quarterly installments of BAHS debt	$ 800
Amount of final Butler Animal Health Supply, LLC debt installment	$ 301,600
LIBOR plus a margin interest rate on BAHS debt (in hundredths)	3.50%
LIBOR floor interest rate on BAHS debt (in hundredths)	2.00%
Butler Debt Refinanced Term-Loan A [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 100,000
Number of quarterly installments to repay debt from BAHS acquisition	14
Butler Debt Term Loan A Quarterly Installment Range One	$ 1,250
Butler Debt Term Loan A Quarterly Installment Range Two	1,880
Butler Debt Term Loan A Quarterly Installment Range Three	2,500
Butler Debt Term Loan A Quarterly Installment Range Four	3,130
Amount of final Butler Animal Health Supply, LLC debt installment	$ 74,400
LIBOR plus a margin interest rate on BAHS debt (in hundredths)	3.00%
Butler Debt Refinanced Term-Loan B [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 216,000
Intercompany Debt Provided Balance Amount	$ 55,000
Number of quarterly installments to repay debt from BAHS acquisition	17
Amount of quarterly installments of BAHS debt	$ 540
Amount of final Butler Animal Health Supply, LLC debt installment	$ 206,800
LIBOR plus a margin interest rate on BAHS debt (in hundredths)	3.25%
LIBOR floor interest rate on BAHS debt (in hundredths)	1.25%
Butler Debt Refinanced-Revolver [Member]
Debt Instrument [Line Items]
Debt Instrument, Face Amount	$ 50,000
LIBOR plus a margin interest rate on BAHS debt (in hundredths)	3.00%
Revolving credit facility [Member]
Line of Credit Facility [Line Items]
Current revolving credit facility borrowing capacity	$ 400,000
Additional credit available under expansion feature of current revolving credit facility	100,000
Outstanding letters of credit provided to third parties	9,700
Line of credit facility, amount outstanding	$ 25,000
Weighted average interest rate on borrowings under credit lines (in hundredths)	0.70%
Various bank credit lines [Member]
Line of Credit Facility [Line Items]
Line of credit facility, amount outstanding	$ 24,200

Redeemable Noncontrolling Interests (Details) - USD ($) $ in Thousands	6 Months Ended	12 Months Ended
	Jun. 25, 2011	Dec. 25, 2010
Components of the change in the Redeemable noncontrolling interests [Abstract]
Balance, beginning of period	$ 304,140	$ 178,570
Net increase in redeemable noncontrolling interests due to business acquisitions, net of redemptions	10,354	62,314
Net income attributable to redeemable noncontrolling interests	16,819	26,054
Dividends declared	(6,081)	(12,360)
Effect of foreign currency translation attributable to redeemable noncontrolling interests	2,192	(2,281)
Change in fair value of redeemable securities	96,740	51,843
Balance, end of period	$ 424,164	$ 304,140

Comprehensive Income (Details) - USD ($) $ in Thousands	3 Months Ended		6 Months Ended
Comprehensive Income (Details) - USD ($) $ in Thousands	Jun. 25, 2011	Jun. 26, 2010	Jun. 25, 2011	Jun. 26, 2010	Dec. 25, 2010
Attributable to Redeemable noncontrolling interests:
Foreign currency translation adjustment	$ 1,328		$ 1,328		$ (864)
Attributable to Henry Schein, Inc.:
Foreign currency translation adjustment	111,893		111,893		41,138
Unrealized gain (loss) from foreign currency hedging activities	750		750		(1,060)
Unrealized investment loss	(979)		(979)		(1,176)
Pension adjustment loss	(8,743)		(8,743)		(8,388)
Accumulated other comprehensive income	102,921		102,921		30,514
Total Accumulated other comprehensive income	104,249		104,249		$ 29,650
Foreign currency translation gain attributable to Redeemable noncontrolling interests	300	$ (4,209)	2,192	$ (7,696)
Comprehensive income, net of applicable taxes [Abstract]
Comprehensive income attributable to Henry Schein, Inc.	107,560	50,845	243,377	76,858
Comprehensive income attributable to noncontrolling interests	143	20	238	33
Comprehensive income attributable to Redeemable noncontrolling interests	10,738	4,933	19,011	7,785
Comprehensive income	$ 118,441	$ 55,798	$ 262,626	$ 84,676

Fair Value Measurements (Details) $ in Thousands	6 Months Ended
Fair Value Measurements (Details) $ in Thousands	Jun. 25, 2011 USD ($)	Jun. 26, 2010 USD ($)	Dec. 25, 2010 USD ($)
Notes to Financial Statements [Abstract]
Number of levels in fair value hierarchy	3
Schedule of investments in auction-rate securities [Line Items]
Minimum length of time to maturity on auction-rate securities (in years)	10
Maximum length of time to maturity on auction-rate securities (in years)	30
Minimum period for interest rates to reset on auction-rate securities (in days)	7
Additional period for interest rates to reset on auction-rate securities (in days)	28
Maximum period for interest rates to reset on auction-rate securities (in days)	35
Cumulative temporary impairment related to closed-end municipal bond funds and student loan portfolio			$ 1,700
Change in cumulative temporary impairment related to closed-end municipal bond funds and student loan portfolio	$ 200
Fair value of debt	443,300		441,300
Assets: [Abstracts]
Available-for-sale securities	11,405		13,367
Derivative contracts - assets	1,463		1,213
Total assets	12,868		14,580
Liabilities: [Abstracts]
Derivative contracts - liabilities	1,057		2,771
Total liabilities	1,057		2,771
Redeemable Noncontrolling Interests [Abstract]
Redeemable noncontrolling interests	424,164		304,140
Auction Rate Securities [Member]
Schedule of investments in auction-rate securities [Line Items]
Amount of investment	12,900
Investment net of temporary impairment	11,400
Redemptions at par of auction-rate securities	2,200
Level 3 (Unobservable Inputs) Closed-End Municipal Bond Funds, Student Loan Backed Auction-Rate Securities, Money Market Fund and Redeemable Noncontrolling Interests [Member]
Fair value of assets, liabilities and redeemable noncontrolling interests, unobservable input reconciliation [Line Items]
Fair value of assets, liabilities and redeemable noncontrolling interests, unobservable input reconciliation balance, beginning of period	317,507	$ 199,164
Change in redeemable noncontrolling interests	120,024	162,529
Redemptions at par	(2,150)	(3,080)
Gain reported in accumulated other comprehensive income	188	102
Fair value of assets, liabilities and redeemable noncontrolling interests, unobservable input reconciliation balance, end of period	435,569	$ 358,715
Level 1 [Member]
Assets: [Abstracts]
Available-for-sale securities	0		0
Derivative contracts - assets	0		0
Total assets	0		0
Liabilities: [Abstracts]
Derivative contracts - liabilities	0		0
Total liabilities	0		0
Redeemable Noncontrolling Interests [Abstract]
Redeemable noncontrolling interests	0		0
Level 2 [Member]
Assets: [Abstracts]
Available-for-sale securities	0		0
Derivative contracts - assets	1,463		1,213
Total assets	1,463		1,213
Liabilities: [Abstracts]
Derivative contracts - liabilities	1,057		2,771
Total liabilities	1,057		2,771
Redeemable Noncontrolling Interests [Abstract]
Redeemable noncontrolling interests	0		0
Level 3 [Member]
Assets: [Abstracts]
Available-for-sale securities	11,405		13,367
Derivative contracts - assets	0		0
Total assets	11,405		13,367
Liabilities: [Abstracts]
Derivative contracts - liabilities	0		0
Total liabilities	0		0
Redeemable Noncontrolling Interests [Abstract]
Redeemable noncontrolling interests	$ 424,164		$ 304,140

Business Acquisitions (Details) $ in Thousands	6 Months Ended	12 Months Ended
Business Acquisitions (Details) $ in Thousands	Jun. 25, 2011 USD ($)	Jun. 30, 2010 USD ($)	Dec. 31, 2010 USD ($)	Dec. 31, 2009 USD ($)
Intangible assets [Abstract]
Notional amount of interest rate caps related to Butler debt	$ 160,000
Interest rate caps on debt protecting against LIBOR interest rate (in hundredths)	3.00%
Trade name [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Average Useful Life (in years)	3
Customer relationships [ Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Average Useful Life (in years)	12
Non-compete agreements [Member]
Finite-Lived Intangible Assets [Line Items]
Finite-Lived Intangible Assets, Average Useful Life (in years)	2
Acquisition of Butler Animal Holding Company, LLC [Member]
Business Acquisition [Line Items]
Acquired equity interest (in hundredths)				50.10%
Butler Schein Animal Health Debt At Closing				$ 320,000
Debt provided by Henry Schein				37,500
Total Consideration For Acquisition [Abstract]
Net cash consideration paid by Henry Schein, Inc.				41,990
Net book value of the United States animal health operations' assets and liabilities contributed				86,048
Fair value of noncontrolling interest in BAHS				96,110
Incremental debt incurred				127,000
Total consideration				351,148
Net assets of BAHS at fair value:
Current assets				164,789
Intangible assets [Abstract]
Trade name				10,000
Customer relationships				140,000
Non-compete agreements				2,600
Business acquisition, purchase price allocation, goodwill amount				270,714
Other assets				14,138
Current liabilities				(62,770)
Bank indebtedness				(200,100)
Deferred income tax liabilities				(74,271)
Contributed net book value of certain assets and liabilities				86,048
Business acquisition, cost of acquired entity, purchase price				$ 351,148
Maximum annual payment to Oak Hill Capital Partners for the first year	$ 125,000
Maximum annual payment to Oak Hill Capital Partners for the second year	137,500
Maximum annual payment to Oak Hill Capital Partners for the third year and thereafter	$ 150,000
Maximum percentage of ownership that Burns Veterinary Supply can sell to the Company.	20.00%
Aggregate maximum amount that the Company will pay to Burns Veterinary Supply and Oak Hill Capital Partners in a given year.	$ 150,000
Provet Holdings Limited [Member]
Business Acquisition [Line Items]
Acquired equity interest (in hundredths)			100.00%
Business acquisition, aggregate sales in year of acquisition of acquired companies		$ 278,000
Total Consideration For Acquisition [Abstract]
Net cash consideration paid by Henry Schein, Inc.			$ 91,000
Debt incurred as part of acquisition of Butler Animal Health Supply, LLC [Member]
Business Acquisition [Line Items]
Number of quarterly installments to repay debt from BAHS acquisition	23
Amount of quarterly installments of BAHS debt	$ 800
Amount of final Butler Animal Health Supply, LLC debt installment	$ 301,600
LIBOR plus a margin interest rate on BAHS debt (in hundredths)	3.50%
LIBOR floor interest rate on BAHS debt (in hundredths)	2.00%
Butler Debt Refinanced Term-Loan A [Member]
Business Acquisition [Line Items]
Debt Instrument, Face Amount	$ 100,000
Number of quarterly installments to repay debt from BAHS acquisition	14
Butler Debt Term Loan A Quarterly Installment Range One	$ 1,250
Butler Debt Term Loan A Quarterly Installment Range Two	1,880
Butler Debt Term Loan A Quarterly Installment Range Three	2,500
Butler Debt Term Loan A Quarterly Installment Range Four	3,130
Amount of final Butler Animal Health Supply, LLC debt installment	$ 74,400
LIBOR plus a margin interest rate on BAHS debt (in hundredths)	3.00%
Butler Debt Refinanced Term-Loan B [Member]
Business Acquisition [Line Items]
Debt provided by Henry Schein	$ 55,000
Debt Instrument, Face Amount	$ 216,000
Number of quarterly installments to repay debt from BAHS acquisition	17
Amount of quarterly installments of BAHS debt	$ 540
Amount of final Butler Animal Health Supply, LLC debt installment	$ 206,800
LIBOR plus a margin interest rate on BAHS debt (in hundredths)	3.25%
LIBOR floor interest rate on BAHS debt (in hundredths)	1.25%
Butler Debt Refinanced-Revolver [Member]
Business Acquisition [Line Items]
Debt Instrument, Face Amount	$ 50,000
LIBOR plus a margin interest rate on BAHS debt (in hundredths)	3.00%

Plan of Restructuring (Details) $ in Thousands	3 Months Ended			6 Months Ended
Plan of Restructuring (Details) $ in Thousands	Jun. 25, 2011 USD ($)	Jun. 26, 2010 USD ($)	Mar. 27, 2010	Jun. 25, 2011 USD ($)	Jun. 26, 2010 USD ($)
Notes to Financial Statements [Abstract]
Positions eliminated from operations (in positions)			184
Restructuring costs	$ 0	$ 0		$ 0	$ 12,285
Restructuring costs after-tax					$ 8,300
Restructuring Reserve [Roll Forward]
Restructuring Reserve, beginning balance				4,343
Provision				0
Payments and other adjustments				1,844
Restructuring Reserve, ending balance	2,499			2,499
Healthcare Distribution [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, beginning balance				4,343
Provision				0
Payments and other adjustments				1,844
Restructuring Reserve, ending balance	2,499			2,499
Technology [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, beginning balance				0
Provision				0
Payments and other adjustments				0
Restructuring Reserve, ending balance	0			0
Severance costs [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, beginning balance				1,992
Provision				0
Payments and other adjustments				1,015
Restructuring Reserve, ending balance	977			977
Facility closing costs [Member]
Restructuring Reserve [Roll Forward]
Restructuring Reserve, beginning balance				2,351
Provision				0
Payments and other adjustments				829
Restructuring Reserve, ending balance	$ 1,522			$ 1,522

Earnings Per Share (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Millions	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 25, 2011	Jun. 26, 2010	Dec. 25, 2010	Sep. 03, 2010
Notes to Financial Statements [Abstract]
Interest rate on redeemed convertible contingent notes (in hundredths)					3.00%
The approximate amount of cash paid to redeem convertible contingent notes					$ 240
The number of shares of common stock issued in redemption of convertible contingent notes (in shares)						732
Weighted-Average Common Shares Outstanding, Basic and Diluted [Abstract]
Basic (in shares)	90,766	90,021	90,710	89,733
Effect of dilutive securities:
Stock options, restricted stock and restricted units (in shares)	2,680	2,286	2,620	2,289
Effect of assumed conversion of convertible debt (in shares)	0	1,045	0	962
Diluted (in shares)	93,446	93,352	93,330	92,984
Weighted-average options to purchase shares - anti-dilutive (in shares)		990	6	990
Weighted-average price per common stock (in dollars per share)			$ 69.45
Minimum price per common stock (in dollars per share)		$ 59.89		$ 59.89
Maximum price per common stock (in dollars per share)		$ 62.05		$ 62.05

Income Taxes (Details) - USD ($) $ in Millions	6 Months Ended
Income Taxes (Details) - USD ($) $ in Millions	Jun. 25, 2011	Jun. 26, 2010
Notes to Financial Statements [Abstract]
Effective tax rate (in hundredths)	32.20%	31.90%
Unrecognized tax benefits	$ 29.0
Total interest	6.1
Total penalties	$ 0.0

Stock-Based Compensation (Details) - USD ($) $ / shares in Units, shares in Thousands, $ in Thousands	3 Months Ended		6 Months Ended		12 Months Ended
	Jun. 25, 2011	Jun. 26, 2010	Jun. 25, 2011	Jun. 26, 2010	Dec. 25, 2010
Notes to Financial Statements [Abstract]
Pre-tax share-based compensation expense	$ 9,600	$ 6,900	$ 17,960	$ 12,999
Share-based compensation expense after-tax	6,500	$ 4,800	12,200	$ 8,900
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Total unrecognized compensation cost related to non-vested awards	$ 84,200		$ 84,200
Weighted average period of recognition for unrecognized compensation costs on nonvested awards (in years)			2.4
Stock options for common stock [Member]
Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions and Methodology [Abstract]
Expected dividend yield (in hundredths)			0.00%		0.00%
Expected stock price volatility (in hundredths)			20.00%		20.00%
Risk-free interest rate (in hundredths)			2.13%		2.37%
Expected life of options (years)			4.75		4.5
Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding [Roll Forward]
Outstanding at beginning of period (in shares)			5,012
Granted (in shares)			10
Exercised (in shares)			(743)
Forfeited (in shares)			(15)
Outstanding at end of period (in shares)	4,264		4,264		5,012
Ending balance, options exercisable (in shares)	3,972		3,972
Weighted Average Price Per Share [Abstract]
Outstanding at beginning of period (in dollars per share)			$ 43.05
Granted (in dollars per share)	$ 69.45		69.45
Exercised (in dollars per share)	37.85		37.85
Forfeited (in dollars per share)	39.72		39.72
Outstanding at end of period (in dollars per share)	44.02		44.02		$ 43.05
Ending balance, options exercisable (in dollars per share)	$ 42.92		$ 42.92
Weighted Average Remaining Contractual Life, Options outstanding (in years)			4.4
Weighted Average Remaining Contractual Life, Options exercisable (in years)			4.2
Aggregate Intrinsic Value, Outstanding at period end	$ 108,750		$ 108,750
Aggregate Intrinsic Value, Options exercisable at period end			$ 105,655
Time-based restricted stock/units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of years for full vesting (in years)			four
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]
Beginning balance outstanding (in shares)			743
Granted (in shares)			230
Vested (in shares)			(85)
Forfeited (in shares)			(8)
Ending balance outstanding (in shares)	880		880		743
Weighted Average Grant Date Fair Value [Abstract]
Beginning balance outstanding (value)			$ 34,804
Granted (value)			15,981
Vested (value)			(4,369)
Forfeited (value)			(381)
Ending balance outstanding (value)	$ 46,035		46,035		$ 34,804
Aggregate intrinsic value	$ 61,212		$ 61,212
Performance-based restricted stock/units [Member]
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Number of years for full vesting (in years)			three
Period over which earnings per share performance is measured against specified targets (in years)			three
Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested [Roll Forward]
Beginning balance outstanding (in shares)			1,347
Granted (in shares)			451
Vested (in shares)			(45)
Forfeited (in shares)			(7)
Ending balance outstanding (in shares)	1,746		1,746		1,347
Weighted Average Grant Date Fair Value [Abstract]
Beginning balance outstanding (value)			$ 42,083
Granted (value)			32,339
Vested (value)			(2,720)
Forfeited (value)			(349)
Ending balance outstanding (value)	$ 71,353		71,353		$ 42,083
Aggregate intrinsic value	$ 121,350		$ 121,350

Supplemental Cash Flow Information (Details) - USD ($) $ in Thousands	6 Months Ended
	Jun. 25, 2011	Jun. 26, 2010
Supplemental Cash Flow Information [Abstract]
Interest	$ 16,159	$ 9,824
Income taxes	81,235	62,642
Non-cash net unrealized gains (losses) related to hedging activities	$ 2,100	$ (23,000)

Document Information	6 Months Ended
Document Information	Jun. 25, 2011
Document Type	10-Q
Amendment Flag	false
Document Period End Date	Jun. 25, 2011

Entity Information - shares	6 Months Ended
Entity Information - shares	Jun. 25, 2011	Jul. 22, 2011
Entity Registrant Name	HENRY SCHEIN INC
Entity Central Index Key	0001000228
Current Fiscal Year End Date	--12-31
Entity Well-known Seasoned Issuer	Yes
Entity Voluntary Filers	No
Entity Current Reporting Status	Yes
Entity Filer Category	Large Accelerated Filer
Entity Common Stock, Shares Outstanding		92,415,293
Document Fiscal Year Focus	2011
Document Fiscal Period Focus	Q2